Sonic hedgehog protein: A novel approach to the treatment of neurodegenerative disorders?

CNS Drugs

Volumn 9, Issue 4, 1998, Pages 253-259

  Pang, Kevin ^a   Ingolia, Thomas D ^a  

^a Ontogeny Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SONIC HEDGEHOG PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DEGENERATIVE DISEASE; DOPAMINERGIC TRANSMISSION; DOSE RESPONSE; DRUG EFFECT; DRUG RESEARCH; NERVE CELL DIFFERENTIATION; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROKE;

EID: 0031897309     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-199809040-00001     Document Type: Article

References (44)

1. Mohler J, Vani K. Molecular organization and embryonic expression of the hedgehog gene involved in cell-cell communication in segmental patterning of Drosophila. Development 1992; 115: 957-71
2. Lee JJ, von Kessler DP, Parks S, et al. Secretion and localized transcription suggest a role in positional signalling for products of the segmentation gene hedgehog. Cell 1992; 71: 33-50
3. Tabata T, Eaton S, Kornberg TB. The Drosophila hedgehog gene is expressed specifically in posterior compartment cells and is a target of engrailed regulation. Genes Dev 1992; 6: 2635-45
4. Tashiro S, Michiue T, Higashijima S, et al. Structure and expression of hedgehog, a Drosophila segment-polarity gene required for cell-cell communication. Gene 1993; 124: 183-9
5. Bitgood S, Shen L, McMahon AP. Sertoli cell signaling by Desert Hedgehog regulates the male germline. Curr Biol 1996; 6: 298-304
6. Vortkamp A, Lee K, Lanske B, et al. Regulation of rate of cartilage differentiation by Indian Hedgehog and PTH-related protein. Science 1996; 273: 613-22
7. Lee JJ, Ekker SC, von Kessler DP, et al. Autoproteolysis in hedgehog protein biogenesis. Science 1994; 266: 1528-37
8. Marti E, Bumcrot DA, Takada R, et al. Requirement of 19K form of Sonic hedgehog for induction of distinct ventral cell types in CNS explants. Nature 1995; 375: 322-5
9. Porter JA, Ekker SC, Park W-J, et al. Hedgehog patterning activity: role of a lipophilic modification mediated by the carboxy-terminal autoprocessing domain. Cell 1996; 86: 21-34
10. Porter JA, Young KE, Beachy PA. Cholesterol modification of hedgehog signaling proteins in animal development. Science 1996; 274: 255-9
11. Lin L-FH, Doherty DH, Lile JD, et al. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 1993; 260: 1130-2
12. Tomac A, Linqvist E, Lin L-FH, et al. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 1995; 373: 335-9
13. Ernfors P, Lee KF, Jenisch R. Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature 1994; 368: 147-50
14. Jones KR, Farinas I, Backus C, et al. Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell 1994; 76: 989-99
15. Eriksson NP, Lindsay RM, Aldskogine H. BDNF and NT-3 rescue sensory but not motor neurons following axotomy in the neonate. Neuroreport 1994; 5: 1445-8
16. Hyman C, Juhasz M, Jackson C, et al. Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J Neurosci 1994; 14: 335-47
17. Beck KD, Knusel B, Hefti F. The nature of the trophic action of brain-derived neurotrophic factor, des(1-3)-insulin-like growth factor-1, and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture. Neuroscience 1993; 52: 855-66
18. Frim DM, Uler TA, Short MP, et al. Effects of biologically delivered NGF, BDNF, and bFGF on striatal excitotoxic lesions. Neuroreport 1993; 4: 367-70
19. Poulsen KT, Armanini MP, Klein RD, et al. TGFβ2 and TGFβ3 are potent survival factors for midbrain dopaminergic neurons. Neuron 1994; 13: 1245-52
20. Kriegelstein K, Suter-Crazzolara C, Fischer WH, et al. TGFβ superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity. EMBO J 1995; 14: 736-42
21. Masu Y, Wolf F, Holtmann B, et al. Disruption of the CNTF gene results in motor neuron degeneration. Nature 1993; 365: 27-32
22. Miyata Y, Kashihara Y, Homma S, et al. Effects of nerve growth factor on the survival and synaptic function of 1a sensory neurons axotomized in neonatal rats. J Neurosci 1986; 6: 2102-18
23. Hayakawa K, Sobue G, Itoh T, et al. Nerve growth factor prevents neurotoxic effects of cisplatin, vincristine, and taxol on adult rat sympathetic ganglion explants in vitro. Life Sci 1994; 55: 519-25
24. Konings PN, Makkink WK, Van Deft AM, et al. Reversal by NGF of cytostatic drug-induced reduction of neurite out-growth in rat dorsal root ganglia in vitro. Brain Res 1994; 640: 195-204
25. Malgrange B, Delree P, Rigo JM, et al. Image analysis of neuritic regeneration by adult rat dorsal root ganglion neurons in culture: quantification of the neurotoxicity of anticancer agents and of its prevention by nerve growth factor or basic fibroblast growth factor but not brain-derived neurotrophic factor or neurotrophin-3. J Neurosci Methods 1994; 53: 111-22
26. Gao W-Q, Dybdal N, Shinsky N, et al. Neurotrophin-3 reverses experimental cisplatin-induced peripheral sensory neuropathy. Ann Neurol 1995; 38: 30-7
27. Hynes MA, Poulsen K, Armanini M, et al. Neurotrophin-4/5 is a survival factor for embryonic midbrain dopaminergic neurons in enriched cultures. J Neurosci Res 1994; 37: 144-54
28. Skaper SD, Leon A, Facci L. Basic fibroblast growth factor modulates sensitivity of cultured hippocampal pyramidal neurons to glutamate cytotoxicity: interaction with ganglio-side GM1. Brain Res Dev Brain Res 1993; 15: 1-8
29. Park TH, Mytilineou C. Protection from 1-methyl-4 phenyl-pyridinium (MPP+) toxicity and stimulation of regrowth of (MPP+) damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and bFGF. Brain Res 1992; 599: 83-97
30. Nikkah G, Odin P, Smits A, et al. Platelet-derived growth factor promotes survival of rat and human mesencephalic dopaminergic neurons in culture. Exp Brain Res 1993; 93: 516-23
31. Giacobini MM, Almstrom S, Funa K, et al. Differential effects of platelet-derived growth factor isoforms on dopamine neurons in vivo: -BB supports cell survival. -AA enhances fiber formation. Neuroscience 1993; 75: 65-73
32. Casper D, Mytilineiou C, Blum M. EGF enhances the survival of dopamine neurons in rat embryonic mesencephalon primary cell culture. J Neurosci Res 1991; 30: 372-81
33. Tanabe Y, Roclink H, Jessell TM. Induction of motor neurons by Sonic hedgehog is independent of floor plate differentiation. Curr Biol 1995; 5: 651-8
34. Echelard Y, Epstein DJ, St-Jacques B, et al. Sonic Hedgehog, a member of a family of putative signaling molecules, is implicated in the regulation of CNS polarity. Cell 1993; 75: 1417-30
35. Hynes M, Porter JA, Chiang C, et al. Induction of midbrain dopaminergic neurons by sonic hedgehog. Neuron 1995; 15: 1-20
36. Wang MZ, Jin P, Bumcrot DA, et al. Induction of dopaminergic neuron phenotype in the midbrain by Sonic hedgehog protein. Nature Med 1995; 1: 1184-7
37. Ericson J, Muhr J, Placzek M, et al. Sonic hedgehog induces the differentiation of ventral forebrain neurons: a common signal for ventral patterning within the neural tube. Cell 1995; 81: 747-56
38. Martinez-Serrano A, Bjorklund A. Protection of the neostriatum against excitotoxic damage by neurotrophin producing, genetically modified neural stem cells. J Neurosci 1996; 16: 4604-16
39. Mochetti I, Wrathall JR. Neurotrophic factors in central nervous system trauma. J Neurotrauma 1995; 12: 853-70
40. Miao N, Wang M, Ott J, et al. Sonic Hedgehog promotes the survival of specific CNS neuron populations and protects these cells from toxic insult in vitro. J Neurosci 1997; 17 (15): 5891-9
41. Quinn N. Drug treatment of Parkinson's disease. BMJ 1995; 310: 575-9
42. Lindsay RM, Altar CA, Cedarbaum JM, et al. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease. Exp Neurol 1993; 124: 103-18
43. Hefti F, Hartikka J, Knusel B. Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative diseases. Neurobiol Aging 1989; 10: 513-55
44. McMahon SB, Priestley JV. Peripheral neuropathies and neurotrophic factors: animal models and clinical perspectives. Curr Opin Neurol 1995; 5: 616-24